[HTML][HTML] Fibrosis regression following hepatitis C antiviral therapy

A Elsharkawy, R Samir, M El-Kassas - World Journal of Hepatology, 2022 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV) infection is one of the most common causes of liver pathology. It is a
major etiological factor of continuous liver injury by triggering an uncontrolled inflammatory …

[HTML][HTML] Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis …

M Hassan, SM Nasr, NA Amin, E El-Ahwany… - Non-coding RNA …, 2023 - Elsevier
Background Liver cancer stem cells (LCSCs) are a subpopulation of tumor cells that can
drive cancer initiation and relapses. Because of their significance, researchers are looking …

The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt

D Sweed, E Sweed, I Moaz, A Mosbeh, Y Fayed… - World Journal of …, 2022 - Springer
Background Hepatocellular carcinoma (HCC) remains a major health problem despite the
emergence of several preventive and therapeutic modalities. HCC has heterogeneous and …

A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapy

SM El-Haggar, DS Attalla, M Elhelbawy… - …, 2025 - Springer
Objective This study aimed to assess the potential antifibrotic impact of zinc sulfate in
chronic Hepatitis C Virus (HCV) patients receiving direct-acting antiviral therapy. Methods …

[PDF][PDF] Disheveled egl-10 and pleckstrin domain-containing 5 rs1012068 t/g gene polymorphism among egyptian chronic hcv-infected patients: disease progression …

HM Farhan, K Abougabal, H Gaber… - Egyptian Journal of …, 2022 - ejimmunology.org
Hepatitis C virus (HCV) infection related complications including fibrosis, cirrhosis and
hepatocellular carcinoma (HCC) are influenced by host genetic factors. Identification of …

[PDF][PDF] REGRESSION OF LIVER FIBROSIS IN HCV CIRRHOTIC PATIENTS TREATED WITH INTERFERON-FREE THERAPIES.

A LEUŞTEAN, MC OLARIU, N MIHAI, C TILIŞCAN… - …, 2024 - farmaciajournal.com
The development of interferon-free treatments for hepatitis C virus (HCV) infection
represents an important milestone in reducing the incidence of chronic HCV and mortality …

Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study

AE Ray, L Castera, A Al-Ashry, S Ghali - Egyptian Liver Journal, 2023 - Springer
Background and study aims Egypt has been a pioneer in implementing a nationwide HCV
screening and treatment program. Assessment of liver fibrosis after HCV eradication is …

Epidemiology, risk factors, and pathogenesis associated with a superbug: a comprehensive literature review on hepatitis C virus infection

M Tariq, AB Shoukat, S Akbar, S Hameed… - SAGE Open …, 2022 - journals.sagepub.com
Viral hepatitis is a major public health concern. It is associated with life threatening
conditions including liver cirrhosis and hepatocellular carcinoma. Hepatitis C virus infects …

Long-term Follow-up of Chronic Hepatitis C Patients Treated by Direct-Acting Antivirals

A Tawheed, M El-Kassas, A El-Fouly… - The Egyptian Journal of …, 2023 - journals.ekb.eg
Background: Hepatitis C virus HCV infection is one of the main causes of chronic liver
disease worldwide, Egypt has the highest national-level HCV prevalence in the world, and …

Hepatitis C Associated B-Cell Non-Hodgkin Lymphoma: Impact of Combination Direct-Acting Antivirals and Chemotherapy

M Budeebazar, D Boldbaatar, K Batsukh… - Central Asian Journal …, 2021 - mongoliajol.info
Objectives: Direct-acting antiviral agents (DAAs) have successfully eradicated chronic
hepatitis C virus (HCV) infection. Since chronic HCV is known to have an increased risk of …